Pöördumine

Saatja: [email protected] <[email protected]> Saaja: [email protected], MERONI Donata, TOKOFAI Anatole, STREY Monika, HARATAU Valerian Theodor, STOYANOV Yavor, 'Hayley.D'[email protected]' Teema: Open Public Consultation (OPC) and targeted stakeholder survey for ex-post evaluation of the 3rd Health Programme Dear Madam, dear Sir, dear colleagues and representatives of the EU Health Programme’s Stakeholders, In the context of the ongoing final evaluation of the EU 3rd Health Programme 2014-2020, the European Commission has launched an Open Public Consultation survey (OPC) survey, to collect feedback on the implementation and performance of the programme. If you haven’t yet replied to this survey, we would be very grateful if you could provide your contribution via the following link: 3rd health programme (2014-2020) – final evaluation (europa.eu)<https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12604-3rd-health-programme-2014-2020-final-evaluation/public-consultation_en> Answering to the online OPC questionnaire will take you around 30 minutes. The survey is open for online participation a few days more, until Friday, 3 June 2022. You may choose to reply to the survey in your own national language or in another EU language by selecting the preferred language on the upper-middle of the main page of the survey. [on the main webpage of the OPC survey, please click on the button EN” in order to select your preferred language]. We would be very grateful if you could also forward the information on the survey to the stakeholders within your networks and areas of work. Should you have any question, please contact us through the e-mail address: [email protected]<mailto:[email protected]>. Thank you very much for your contribution to the evaluation of the 3rd Health programme. [cid:[email protected]] With kind regards, on behalf of the Third Health Programme Evaluation Team Monika Strey [cid:[email protected]] EUROPEAN COMMISSION Directorate-General for Health & Food Safety SANTE C1 – Health Promotion, Disease Prevention, Financial Instruments